OIA response: Pembrolizumab and nivolumab

Special Authority data on pembrolizumab and nivolumab, from Jan 2020 to May 2020.

19 June 2020 


[name and contact details redacted] 

Dear [name redacted] 

REQUEST FOR INFORMATION: 

Thank you for your email of 28 May 2020.  You have asked for Special Authority data on pembrolizumab and nivolumab, from Jan 2020 to May 2020. 

The information you have requested is tabulated below.  This information is released pursuant to the Official Information Act 1982.

Pembrolizumab – SA1615 SA1657

Month submitted

Initial Applications

Approvals - initial

Renewal Applications

Approval - Renewal

Total applications

Total approvals

2020-01-01

31

27

53

42

84

69

2020-02-01

14

14

53

49

67

63

2020-03-01

19

17

55

51

74

68

2020-04-01

35

30

45

36

80

66

2020-05-01

31

31

21

19

52

50

Nivolumab – SA1656 SA1602 SA1617 

Month submitted

Initial Applications

Approvals - initial

Renewal Applications

Approval - Renewal

Total applications

Total approvals

2020-01-01

0

0

0

<10

0

<10

2020-02-01

0

0

0

0

0

0

2020-03-01

0

0

<10

<10

<10

<10

2020-04-01

0

0

0

0

0

0

2020-05-01

0

0

0

0

0

0

Note that PHARMAC has changed a small amount of information in the tables to protect the privacy of natural persons (section 9(2)(a) of the OIA).  This is when the data refers to numbers of less than 10 individuals.  In these instances, the value has been changed to <10.

As required under the OIA, we also considered whether, in the circumstances, the withholding of this information was outweighed by other considerations which render it desirable, in the public interest, to make this information available.  In this case we did not consider that the public interest outweighed the reasons for withholding the information.

Please note you have the right, by way of complaint under section 28(3) of the OIA to an Ombudsman, to seek an investigation and review of our decision.

We are making our information more freely available, so we will now publish selected Official Information Act responses (excluding personal details) on our website.  Please get in touch with us if you have any questions about this.

Yours sincerely

Rachel Read
Manager, Policy and Government Services